Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 9

1.

Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE Cohort.

Préau M, Laguette V, March L, Rabaud C, Hardel L, Protopopescu C, Granier P, Pierret J, Leport C, Raffi F; ANRS CO8 APROCO-COPILOTE Study Group.

AIDS Behav. 2016 Feb 24. [Epub ahead of print]

PMID:
26910336
2.

Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.

Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, Le Moing V, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group.

Antivir Ther. 2015;20(7):763-72. doi: 10.3851/IMP2960. Epub 2015 Apr 10.

PMID:
25859625
3.

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.

Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J; ANRS CO8 APROCO-COPILOTE Cohort Study Group.

J Antimicrob Chemother. 2015;70(6):1816-24. doi: 10.1093/jac/dkv036. Epub 2015 Mar 1.

4.

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.

Richert L, Doussau A, Lelièvre JD, Arnold V, Rieux V, Bouakane A, Lévy Y, Chêne G, Thiébaut R; Vaccine Research Institute (VRI).

Trials. 2014 Feb 26;15:68. doi: 10.1186/1745-6215-15-68.

5.

Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.

Protopopescu C, Raffi F, Brunet-François C, Salmon D, Verdon R, Reboud P, Carrieri MP, Leport C, Spire B, Michel L; APROCO-COPILOTE (ANRS CO8) Study Group.

Antivir Ther. 2012;17(6):1079-83. doi: 10.3851/IMP2102. Epub 2012 Apr 27.

PMID:
22544079
6.

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.

Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G; ANRS CO8 APROCO-COPILOTE Cohort Study Group.

AIDS. 2012 Jan 28;26(3):303-14. doi: 10.1097/QAD.0b013e32834e8776.

PMID:
22089377
7.

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.

Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B; Anrs Co8 Aproco-Copilote Study Group.

AIDS Care. 2012;24(4):434-43. doi: 10.1080/09540121.2011.613909. Epub 2011 Oct 14.

PMID:
21999644
8.

Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy.

Masquelier B, Taieb A, Reigadas S, Marchou B, Cheneau C, Spire B, Charpentier C, Leport C, Raffi F, Chêne G, Descamps D; APROCO-COPILOTE study group.

J Antimicrob Chemother. 2011 Jul;66(7):1582-9. doi: 10.1093/jac/dkr153. Epub 2011 Apr 27.

9.

Commentary on 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD).

Mofenson H, Becker C, Kimbrough R, Lawrence R, Lovejoy F, Winters W, Carracio TR, Hardel LK, Rumack BH, Spyker D.

Vet Hum Toxicol. 1985 Oct;27(5):434-8.

PMID:
4060565
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk